BIO vs EXLS · rev $2.58B vs P/E 19, rev $1.84B
BIO (BIO) versus ExlService Holdings Inc (EXLS) — a side-by-side from cached financials, not a winner call.
BIO (BIO) common stock.
ExlService Holdings Inc (EXLS) is a information technology services company listed on US.
Latest reported BIO revenue for 2025-12-31 was $2.58B. Net income was $759.9M. Revenue was up 0.7% from 2024-12-31 to 2025-12-31. BIO currently screens at market cap $0.
Latest reported EXLS revenue for 2024-12-31 was $1.84B. Net income was $198.3M. Revenue was up 12.7% from 2023-12-31 to 2024-12-31. EXLS currently screens at market cap $4.53B and trailing P/E 18.9.
BIO currently screens at market cap $0. EXLS currently screens at market cap $4.53B and trailing P/E 18.9.
Not investment advice. Open the BIO and EXLS stock pages for the full models.
Not investment advice.